Elite Pharmaceuticals ELTP
OTC ELTP
$0.37 +0.05 (+15.63%)
At close: Nov 16, 2026 · 4:00 PM EST

Elite Pharmaceuticals (ELTP) Cash from Financing Activities (2009 - 2026)

Updated

Elite Pharmaceuticals' Cash from Financing Activities came in at -$266,362 for fiscal Q2 2027 (quarter ended Sep 30, 2026), compared with -$116,468 a year earlier.

Analysis

Elite Pharmaceuticals (ELTP) Cash from Financing Activities (2009 - 2026) Analysis & Trends

Over the trailing twelve months to Sep 30, 2026, Elite Pharmaceuticals reported Cash from Financing Activities of -$456,113; for FY2026 (ended Mar 31, 2026), it was -$4.32 million.

  • Going back by fiscal year, Cash from Financing Activities was -$825,740 in FY2025, $3.34 million in FY2024 (+96.2%), $1.7 million in FY2023 and -$667,133 in FY2022.
  • The fiscal Q2 2027 figure represents the lowest quarterly Cash from Financing Activities since fiscal Q1 2026.
  • Business Quant data shows ELTP's Cash from Financing Activities at -$114,594 (Q1 2027), -$41,522 (Q4 2026) and -$33,635 (Q3 2026) in the three fiscal quarters before Q2 2027.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn -7.22 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn -8.53 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 6.82 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn -2.43 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn 6.63 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn -4.39 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn -1.53 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn -2.51 Bn
10 Elite Pharmaceuticals 401.23 Mn 274.64 Mn 15.99 Mn -266,362.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -266,362.00
Jun 30, 2026 -114,594.00
Mar 31, 2026 -41,522.00
Dec 31, 2025 -33,635.00
Sep 30, 2025 -116,468.00
Jun 30, 2025 -4.13 Mn
Mar 31, 2025 -137,044.00
Dec 31, 2024 -193,104.00
Sep 30, 2024 -320,686.00
Jun 30, 2024 -174,906.00
Mar 31, 2024 -400,969.00
Dec 31, 2023 -37,575.00
Sep 30, 2023 -179,498.00
Jun 30, 2023 3.96 Mn
Mar 31, 2023 -12.50 Mn
Dec 31, 2022 -77,369.00
Sep 30, 2022 2.39 Mn
Jun 30, 2022 11.90 Mn
Mar 31, 2022 -94,244.00
Dec 31, 2021 -153,864.00
API Access

Elite Pharmaceuticals Cash from Financing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=ELTP&period=max&api_key=YOUR_API_KEY